HALOZYME THERAPEUTICS, INC. - Common Stock (HALO)

480 filings reported holding HALO - HALOZYME THERAPEUTICS, INC. - Common Stock as of Q1 2024.
HALOZYME THERAPEUTICS, INC. - Common Stock (HALO) has 409 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 123,583,310 shares of 123,650,000 outstanding shares and own 100% of the company stock.
Largest 10 shareholders include BlackRock Inc. (18,241,548 shares), VANGUARD GROUP INC (13,049,253 shares), STATE STREET CORP (6,487,303 shares), SNYDER CAPITAL MANAGEMENT L P (4,117,227 shares), Artisan Partners Limited Partnership (3,791,230 shares), ALLIANCEBERNSTEIN L.P. (3,666,324 shares), JPMORGAN CHASE & CO (3,240,497 shares), GEODE CAPITAL MANAGEMENT, LLC (3,027,384 shares), MACQUARIE GROUP LTD (2,991,125 shares), and TD Asset Management Inc (2,541,266 shares).
This table shows the top 409 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.